Rubeta N Matin (Rubeta Matin, R Matin, R N Matin)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 33

Top Topics

Squamous Cell Carcinoma

Artificial Intelligence

Top Venues

Clinical and experimental dermatology

The British journal of dermatology

PLOS digital health

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Rubeta N Matin
Widening the scope of AI applications in dermatology. Clinical and experimental dermatology (2024)
Rubeta N Matin
Widening the scope of artificial intelligence applications in dermatology. Clinical and experimental dermatology 49 (7) (2024)
Rubeta N Matin
Widening the scope of artificial intelligence applications in dermatology. Clinical and experimental dermatology 49 (7) (2024)
Veronica Melchionda, Eleni Ieremia, Rubeta N Matin, Tess McPherson
Five paediatric patients with mycosis fungoides and our approach to provide age-appropriate information and psychological support. Clinical and experimental dermatology 49 (5) (2024)
Veronica Melchionda, Eleni Ieremia, Rubeta N Matin, Tess McPherson
Five paediatric patients with mycosis fungoides and our approach to provide age-appropriate information and psychological support. Clinical and experimental dermatology 49 (5) (2024)
Veronica Melchionda, Eleni Ieremia, Rubeta N Matin, Tess McPherson
Five paediatric patients with mycosis fungoides and our approach to provide age-appropriate information and psychological support. Clinical and experimental dermatology 49 (5) (2024)
William John Wallace, Calvin Chan, Swathikan Chidambaram, Lydia Hanna, Amish Acharya, Elisabeth Daniels, Pasha Normahani, Rubeta N Matin, Sheraz R Markar, Viknesh Sounderajah, Xiaoxuan Liu, Ara Darzi
Evaluating the diagnostic and triage performance of digital and online symptom checkers for the presentation of myocardial infarction; A retrospective cross-sectional study. PLOS digital health 3 (8) (2024)
Veronica Melchionda, Eleni Ieremia, Rubeta N Matin, Tess McPherson
Five paediatric mycosis fungoides cases and our approach to provide age-appropriate information and psychological support. Clinical and experimental dermatology (2024)
Veronica Melchionda, Eleni Ieremia, Rubeta N Matin, Tess McPherson
Five paediatric patients with mycosis fungoides and our approach to provide age-appropriate information and psychological support. Clinical and experimental dermatology 49 (5) (2024)
William John Wallace, Calvin Chan, Swathikan Chidambaram, Lydia Hanna, Amish Acharya, Elisabeth Daniels, Pasha Normahani, Rubeta N Matin, Sheraz R Markar, Viknesh Sounderajah, Xiaoxuan Liu, Ara Darzi
Evaluating the diagnostic and triage performance of digital and online symptom checkers for the presentation of myocardial infarction; A retrospective cross-sectional study. PLOS digital health 3 (8) (2024)
Birgitta van Bodegraven, Sally Vernon, Charlotte Eversfield, Ruth Board, Paul Craig, Sonia Gran, Catherine A Harwood, Stephen Keohane, Nick J Levell, Rubeta N Matin, Charlotte M Proby, Neil Rajan, Brian Rous, Anna Ascott, George W M Millington, Zoe C Venables, null null
"Get Data Out" Skin: national cancer registry incidence and survival rates for all registered skin tumour groups for 2013-2019 in England. The British journal of dermatology (2023)
Muhammad Hyder Junejo, Sibel Demirel, Rubeta N Matin, Charlotte M Proby, Catherine A Harwood
CorrespondenceShort shock or slow burn? Patient perspectives on treatment of actinic keratoses with 5-fluorouracil 5% cream monotherapy versus 5-fluorouracil plus calcipotriol combination therapy. Clinical and experimental dermatology 48 (1) (2023)
Laura Kelly, Laura Coote, Jacqueline Dinnes, Colin Fleming, Hayden Holmes, Rubeta N Matin
Key issues when considering adopting a skin cancer diagnostic tool which uses artificial intelligence. The British journal of dermatology (2023)
Dorothy D Yang, Kim Borsky, Chinmay Jani, Conor Crowley, Jeremy N Rodrigues, Rubeta N Matin, Dominic C Marshall, Justin D Salciccioli, Joseph Shalhoub, Richard James Goodall
Trends in keratinocyte skin cancer incidence, mortality and burden of disease in 33 countries between 1990 and 2017. The British journal of dermatology 188 (2) (2023)
Birgitta van Bodegraven, Sally Vernon, Charlotte Eversfield, Ruth Board, Paul Craig, Sonia Gran, Catherine A Harwood, Stephen Keohane, Nick J Levell, Rubeta N Matin, Charlotte M Proby, Neil Rajan, Brian Rous, Anna Ascott, George W M Millington, Zoe C Venables, null null
"Get Data Out" Skin: national cancer registry incidence and survival rates for all registered skin tumour groups for 2013-2019 in England. The British journal of dermatology (2023)
Sabrina Khan, Ruth Asher, William Perkins, Rubeta N Matin
Cutaneous leiomyosarcoma: a retrospective review of 45 cases. Clinical and experimental dermatology (2023)
Alexa Shipman, Rubeta N Matin
Special issue on artificial intelligence: call for papers. Clinical and experimental dermatology (2023)
Anmol Arora, Joseph Edward Alderman, Joanne Palmer, Shaswath Ganapathi, Elinor Laws, Melissa Danielle McCradden, Lauren Oakden-Rayner, Stephen R Pfohl, Marzyeh Ghassemi, Francis McKay, Darren Treanor, Negar Rostamzadeh, Bilal Akhter Mateen, Jacqui Gath, Adewole O Adebajo, Stephanie Kuku, Rubeta N Matin, Katherine Heller, Elizabeth Sapey, Neil J Sebire, Heather Cole-Lewis, Melanie Jane Calvert, Alastair Keith Denniston, Xiaoxuan Liu
The value of standards for health datasets in artificial intelligence-based applications. Nature medicine (2023)
Dorothy D Yang, Kim Borsky, Chinmay Jani, Conor Crowley, Jeremy N Rodrigues, Rubeta N Matin, Dominic C Marshall, Justin D Salciccioli, Joseph Shalhoub, Richard James Goodall
Trends in keratinocyte skin cancer incidence, mortality and burden of disease in 33 countries between 1990 and 2017. The British journal of dermatology 188 (2) (2023)
Anusuya Kawsar, Charlotte Edwards, Pooja Patel, Richard M Heywood, Aakriti Gupta, Jasmine Kaur Mann, Christopher Harland, Kara Heelan, James M G Larkin, Paul C Lorigan, Catherine A Harwood, Rubeta N Matin, Louise Fearfield
Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational study. The British journal of dermatology 187 (6) (2022)
Rachel Mary Fisher, Antonio Ji-Xu, Rachel Abbott, Tanya Basu, Alistair Brown, Catherine Foley, Catriona Glen, Girish Gupta, Zeeshaan Hasan, Ferina Ismail, Amina Khalid, Andre Boo Shern Khoo, Dimitra Koumaki, Aoife Lally, John T Lear, Emily Jane McGrath, Kein McKenna, Alan Milligan, Orlagh Mulholland, Fiona Tasker, Catherine A Harwood, Charlotte M Proby, Rubeta N Matin
Clinicopathological characteristics of individuals with coexisting melanoma and chronic lymphocytic leukaemia: a multicentre cohort study. Clinical and experimental dermatology 47 (11) (2022)
Joshua Phillip Totty, Rubeta N Matin, Aaron G H Wernham, Ruby Ray, Emma Thomas-Jones, Rachel Angharad Abbott
Use of perioperative prophylactic antibiotics following excision of ulcerated skin lesions in the UK: a national, multispeciality survey of clinicians. Clinical and experimental dermatology 47 (5) (2022)
Chidiebere Hope Nwolise, Agata Rembielak, Ray Fitzpatrick, Crispin Jenkinson, Jerry Marsden, Patricia Fairbrother, Charlotte M Proby, Catherine A Harwood, Rubeta N Matin
Adjuvant radiotherapy in patients with high-risk cutaneous Squamous Cell Carcinoma After surgery (SCC-AFTER): patient and carer views regarding a proposed clinical trial. Clinical and experimental dermatology 47 (10) (2022)
Antonio Ji-Xu, Jacqueline Dinnes, Rubeta N Matin
Establishing the use of total body photography among UK dermatologists. Clinical and experimental dermatology (2021)
C Morton, Rubeta N Matin
Embracing artificial intelligence: how can we make it inclusive and relevant for real-world dermatological practice? The British journal of dermatology (2021)
Weiyu Ye, M Kim, B P Fairfax, N Coupe, M J Payne, Rubeta N Matin
Phenotyping of cutaneous toxicities in patients with metastatic malignant melanoma treated with immune checkpoint blockade therapy at a UK tertiary care centre. Clinical and experimental dermatology (2021)
Rachel Angharad Abbott, A Cordaro, B Lloyd, R Cannings-John, M Wootton, N Kirby, T Pickles, A McQueen, M Westmoreland, S Ziaj, A Martin-Clavijo, Aaron G H Wernham, Rubeta N Matin, E Thomas-Jones
Observational study to estimate the proportion of surgical site infection following excision of ulcerated skin tumours (OASIS study). Clinical and experimental dermatology (2021)
Chidiebere Hope Nwolise, Pippa Corrie, Ray Fitzpatrick, Avinash Gupta, Crispin Jenkinson, Mark Middleton, Rubeta N Matin
Burden of cancer trial participation: A qualitative sub-study of the INTERIM feasibility RCT. Chronic illness (2021)
Maria Charalambides, Carsten Flohr, Philippe Bahadoran, Rubeta N Matin
New international reporting guidelines for clinical trials evaluating effectiveness of artificial intelligence interventions in dermatology: strengthening the SPIRIT of robust trial reporting. The British journal of dermatology 184 (3) (2021)
Antonio Ji-Xu, Jacqueline Dinnes, Rubeta N Matin
Total body photography for the diagnosis of cutaneous melanoma in adults: a systematic review and meta-analysis. The British journal of dermatology 185 (2) (2021)
Ankit Patel, Lucia Fraile Garcia, Viviana Mannella, Luke Gammon, Tiffanie-Marie Borg, Tania Maffucci, Maria Scatolini, Giovanna Chiorino, Elisabetta Vergani, Monica Rodolfo, Andrea Maurichi, Christian Posch, Rubeta N Matin, Catherine A Harwood, Daniele Bergamaschi
Targeting p63 Upregulation Abrogates Resistance to MAPK Inhibitors in Melanoma. Cancer research 80 (12) (2020)
Rubeta N Matin, Eleni Ieremia
Cutaneous Epstein-Barr virus-associated smooth muscle tumor in immunosuppression. Journal of cutaneous pathology 48 (2) (2020)
Rubeta N Matin, R Danby, E Gibbons, V Venning, L Rowley, D Barton, R Pawson, T Littlewood, J R Reed, A Peniket
Developing a dedicated dermatology service for allogeneic bone marrow transplant recipients. The British journal of dermatology 177 (6) (2017)